FMC Corporation

FMC Corporation has been granted 146 US utility patents between 2015 and 2025, placing FMC Corporation at rank #2,657 across all assignees tracked by PlainPatent. This portfolio spans 55 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.6 claims per patent with primary concentration in A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS). As a US Corporation, FMC Corporation is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 56.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 79 grants, compared with 67 in the 2015–2019 window — a +18% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. FMC Corporation's 13.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 55 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark FMC Corporation against peers pursuing similar technology classes.